EPISODE · Sep 27, 2021 · 4 MIN
S2 Ep1: Highlighting results from first FDA-reported study for treatment of presbyopia
from EyePod · host Ophthalmology Times
George O. Waring IV, MD, FACS, discusses the latest results from the GEMINI 1 clinical trial (by Allergan, an Abbvie company) of AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia.
Embed this episode
NOW PLAYING
S2 Ep1: Highlighting results from first FDA-reported study for treatment of presbyopia
0:00
4:17
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Eye Podcast
Nature Publishing Group
EyePod, the podcast from the journal Eye, highlights the best news and research in ophthalmology, including interviews with the people behind the science, in-depth commentary and analysis, and special reports on conferences and meetings.
EyePod: Podcasts from Ophthalmology Times
EyePod: Podcasts from Ophthalmology Times
Introducing EyePod, podcasts by Ophthalmology Times. This new audible resource from Ophthalmology Times engages with key opinion leaders in interviews about the latest innovations in the areas of surgery, clinical diagnosis, pharmaceutical advancements, research, and technology, plus practice management.
The Layman Eyepod Radio Show
Rex C.
A Podcast on everything about the Window of Our Soul - The Eye. In the simplest manner possible so every layman can understand.
Eye Podcast
Erika Mortensen and Christina
EyePod, the podcast from the journal Eye, highlights the best news and research in ophthalmology, including interviews with the people behind the science, in-depth commentary and analysis, and special reports on conferences and meetings.
Frequently Asked Questions
How long is this episode of EyePod?
This episode is 4 minutes long.
When was this EyePod episode published?
This episode was published on September 27, 2021.
Can I download this EyePod episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!